Showing 6101-6110 of 23168 results for "".
Why We'll Never Cure Cancer?
https://reachmd.com/programs/clinicians-roundtable/why-well-never-cure-cancer/2389/What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our GuestWhat Does the Chronic Fatigue Research Reveal?
https://reachmd.com/programs/clinicians-roundtable/what-does-the-chronic-fatigue-research-reveal/825/Join Dr. Jacob Teitelbaum, Director of the Fibromyalgia & Fatigue Centers and author of "From Fatigued to Fantastic" discuss the latest research, and treatment of chronic fatigue.Emergency Department-Scope of Practice
https://reachmd.com/programs/clinicians-roundtable/emergency-department-scope-of-practice/395/Dr. William Maloney, Chair of the Department of Emergency Medicine at Condell Medical Center, discusses the level of expertise needed for the diverse scope of care required in the ED today.Navigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
https://reachmd.com/programs/clinicians-roundtable/navigating-pediatric-obesity-tools-and-strategies-for-success-in-primary-care/37868/Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it’s also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that supporBeyond Plaques: Treatment Challenges and Strategies in Palmoplantar Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/beyond-plaques-treatment-challenges-and-strategies-in-palmoplantar-psoriasis/32442/Palmoplantar psoriasis is a high-impact, functionally burdensome condition that often resists conventional therapies. Characterized by painful fissures, thickened plaques, and distinct immune drivers, it requires a treatment approach beyond what's used for classic plaque psoriasis. To learn more, DrExamining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
https://reachmd.com/programs/project-oncology/examining-real-world-ibrutinib-outcomes-in-rr-mcl-findings-from-a-danish-study/37209/A recent Danish population-based study evaluating real-world outcomes of ibrutinib in relapsed or refractory mantle cell lymphoma (MCL) found lower efficacy and tolerability compared to clinical trials, particularly among older patients and those with high-risk disease features. In this AudioAbstracNemluvio Gains Two Major Indications in Europe
https://reachmd.com/series/dermwire-tv/nemluvio-gains-two-major-indications-in-europe/32982/In this week's DermwireTV, Nemluvio is approved for two new indications in Europe; new patient-centric guidelines for generalized pustular psoriasis (GPP) management are unveiled; and in our C-Suite Chats feature, we are joined by the Co-Founder and CEO of Veradermics.'Combination Is Back,' Doctor Declares at Maui Derm
https://reachmd.com/programs/practical-dermatology/combination-is-back-doctor-declares-at-maui-derm/32918/One of the most important studies of the past few years for dermatologists involved patients with ulcerative colitis, according to Arthur Kavanaugh, MD.- Risk Stratification Testing for Melanomahttps://reachmd.com/series/c-suite-chats/risk-stratification-testing-for-melanoma/32838/Derek Maetzold, president and CEO of Castle Biosciences, discusses the importance of personalized management and treatment approaches for patients diagnosed with melanoma, and how gene expression profile testing can help.
Embracing the Natural Look Movement
https://reachmd.com/ma-issues-index/2025-jan-feb/embracing-the-natural-look-movement/35416/Aesthetic professionals who rely on filler as part of their business model may be worried that the natural look movement will hurt their business, but they should not be.